home : about us : ahead of print : current issue : archives search instructions : subscriptionLogin 
Users online: 83      Small font sizeDefault font sizeIncrease font size Print this page Email this page
Year : 2018  |  Volume : 13  |  Issue : 4  |  Page : 462-464

Congenital muscular dystrophy due to novel compound heterozygote mutations in POMGNT1 gene

1 Department of Physiotherapy and Rehabilitation, Hasan Kalyoncu University, School of Health Sciences, Gaziantep, Turkey, Department of Radiology, Medical Park Hospital, Gaziantep, Turkey
2 Department of Radiology, Medical Park Hospital, Gaziantep, Turkey

Correspondence Address:
Dr. Sedat Isikay
Department of Pediatric Neurology, Medical Park Hospital, 52063 street, Şehitkamil, Gaziantep. Tel: +90 (342) 211 16 00, GSM: +90 546 848 1977, Fax: +90 (342) 324 88 60
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/JPN.JPN_36_18

Rights and Permissions

Muscular dystrophy-dystroglycanopathy is a heterogeneous group of inherited muscular dystrophies caused by glycosylation defects associated with different mutations. The main finding of the disease is disruption of the binding of cellular α-dystroglycan to its extracellular matrix ligands. O-mannose β-1,2-N-acetylglucosaminyltransferase 1 is one of the pathogenic genes involved in glycosylation defects of α-dystroglycan. Herein, we report a patient diagnosed with muscular dystrophy-dystroglycanopathy 3 with the determination of a compound heterozygote novel mutation on O-mannose β-1,2-N-acetylglucosaminyltransferase 1 gene, which was not reported before in literature.


Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded30    
    Comments [Add]    

Recommend this journal